Your browser doesn't support javascript.
loading
Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy.
Honeyborne, Isobella; McHugh, Timothy D; Kuittinen, Iitu; Cichonska, Anna; Evangelopoulos, Dimitrios; Ronacher, Katharina; van Helden, Paul D; Gillespie, Stephen H; Fernandez-Reyes, Delmiro; Walzl, Gerhard; Rousu, Juho; Butcher, Philip D; Waddell, Simon J.
Afiliación
  • Honeyborne I; Centre for Clinical Microbiology, University College London, London, NW3 2PF, UK.
  • McHugh TD; Centre for Clinical Microbiology, University College London, London, NW3 2PF, UK.
  • Kuittinen I; Department of Computer Science, Helsinki Institute for Information Technology HIIT, Aalto University, Espoo, Finland.
  • Cichonska A; Department of Computer Science, Helsinki Institute for Information Technology HIIT, Aalto University, Espoo, Finland.
  • Evangelopoulos D; Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
  • Ronacher K; Centre for Clinical Microbiology, University College London, London, NW3 2PF, UK.
  • van Helden PD; Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research and Medical Research Council Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Western
  • Gillespie SH; Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research and Medical Research Council Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Western
  • Fernandez-Reyes D; Medical and Biological Sciences Building, University of St Andrews, North Haugh, St Andrews, Fife, KY16 9TF, UK.
  • Walzl G; Department of Computer Science, University College London, Gower Street, London, WC1E 6BT, UK.
  • Rousu J; Department of Paediatrics, University College Hospital, College of Medicine of the University of Ibadan, Ibadan, Nigeria.
  • Butcher PD; Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research and Medical Research Council Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Western
  • Waddell SJ; Department of Computer Science, Helsinki Institute for Information Technology HIIT, Aalto University, Espoo, Finland.
BMC Med ; 14: 68, 2016 Apr 07.
Article en En | MEDLINE | ID: mdl-27055815
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / ARN Mensajero / Monitoreo de Drogas / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / ARN Mensajero / Monitoreo de Drogas / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido